| Patents for C07D 405 - Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom (69,397) |
|---|
| 03/31/2011 | WO2011015646A3 Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders |
| 03/31/2011 | WO2010132852A3 Protease inhibitors |
| 03/31/2011 | WO2010085377A3 Hydroxamic acid derivatives |
| 03/31/2011 | US20110077399 Substituted Azole Derivatives as Therapeutic Agents |
| 03/31/2011 | US20110077280 Hepatitis C Virus Inhibitors |
| 03/31/2011 | US20110077246 Bicyclic heterocyclic compounds pharmaceutical compositions containing these compounds, their use and process for preparing the same |
| 03/31/2011 | US20110077245 Substituted 2-alkyl quinazolinone derivatives as parp inhibitors |
| 03/31/2011 | US20110077242 Diaminopyrimidines as p2x3 and p2x2/3 antagonists |
| 03/31/2011 | US20110077160 Pesticides |
| 03/31/2011 | US20110077156 Herbicidal pyrimidines |
| 03/31/2011 | US20110076286 Methods of inhibiting unwanted cell proliferation using hedgehog antagonists |
| 03/31/2011 | CA2775601A1 4-(substituted anilino)-quinazoline derivatives useful as tyrosine kinase inhibitors |
| 03/31/2011 | CA2771026A1 Indole derivatives as crac modulators |
| 03/30/2011 | EP2301940A1 Epothilone derivatives |
| 03/30/2011 | EP2301935A1 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes |
| 03/30/2011 | EP2301934A1 Nitrocatechol derivatives as COMT inhibitors |
| 03/30/2011 | EP2301933A1 Thiopyrimidine derivative, useful as an intermediate for chemokine receptor modulators |
| 03/30/2011 | EP2301932A1 Novel ligands for sensitizing dyes of dye-sensitized solar cells |
| 03/30/2011 | EP2301931A1 Imidazoles as aldosterone synthase inhibitors |
| 03/30/2011 | EP2301930A1 Thrombin receptor antagonists |
| 03/30/2011 | EP2301923A1 New compounds |
| 03/30/2011 | EP2301544A1 Quinoline derivatives as intermediates to mycobacterial inhibitors |
| 03/30/2011 | EP2300458A1 Substituted 1-(diazinyl) pyrazole-4-yl-acetic acids, method for the production thereof, and use thereof as herbicides and plant growth regulators |
| 03/30/2011 | EP2300440A1 3,4-dihydropyrimidine trpa1 antagonists |
| 03/30/2011 | EP2300438A1 Imidazole derivatives useful as inhibitors of faah |
| 03/30/2011 | EP2300433A1 Hiv integrase inhibitors from pyridoxine |
| 03/30/2011 | EP2300427A1 Urea compounds as gamma secretase modulators |
| 03/30/2011 | EP2300423A1 Substituted 7-sulfanylmethyl, 7-sulfinylmethyl and 7-sulfonylmethyl indoles and use thereof |
| 03/30/2011 | EP1877403B1 Mono-lysine salts of azole compounds |
| 03/30/2011 | EP1277738B1 Condensed heteroaryl derivatives |
| 03/30/2011 | CN1966500B Quinoxaline derivative, preparation method and uses |
| 03/30/2011 | CN1898210B 2-pyridinylethylcarboxamide derivatives and their use as fungicides |
| 03/30/2011 | CN1489583B Novel physiologically active substance |
| 03/30/2011 | CN101998954A Conformationally restricted biphenyl derivatives for use as hepatitis c virus inhibitors |
| 03/30/2011 | CN101998951A Acylthiourea compound or salt thereof, and use thereof |
| 03/30/2011 | CN101998852A Novel estrogen receptor ligands |
| 03/30/2011 | CN101993436A Method for preparing imidazole antifungal medicine derivate |
| 03/30/2011 | CN101993416A Quinoline compound and preparation method thereof, medicament combination containing compound and application of compound |
| 03/30/2011 | CN101993410A Organic light-emitting device |
| 03/30/2011 | CN101270116B Neutral-amphiprotic bond-connection type second order nonlinear optics chromogen and synthesizing process thereof |
| 03/29/2011 | US7915433 Tri-substituted 2-benzhydryl 5-benzlamino-tetrahydro-pyran-4-OL and 6-benzhydryl-4-benzylamino-tetrahydro-pyran-3-OL analogues, and novel 3,6 disubstituted pyran derivatives |
| 03/29/2011 | US7915301 Inhibitors of cyclin dependent kinases and their use |
| 03/29/2011 | US7915295 Viricides; HIV antivirals effective against problematic drug escape mutants; N-[(1S,1aR,7bR)-4,7-difluoro-1,1a,2,7b-tetrahydrocyclopropa[c]chromen-1-yl]-N'-[5-(4-(sulfonamido)phenoxy)-2-pyridinyl]urea |
| 03/29/2011 | US7915288 1-aryl-4-substituted isoquinolines |
| 03/29/2011 | US7915274 Nitrogen containing heterocyclic compounds and medicines containing the same |
| 03/29/2011 | US7915268 And 8-substituted 2-(imidazolo[4,5-c]pyridinyl)purines; Janus kinase 3 inhibitors; autoimmune diseases, inflammatory disease, mast cell mediated disease and transplant rejection |
| 03/29/2011 | US7915249 serotonin 5-HT2A, 5-HT2C and dopamin D2 receptors antagonist, and norepinephrine reuptake inhibitor; antidepressant, anxiolytic agent; psychosis, schizophrenia, bipolar and sexual disorders, obesity |
| 03/29/2011 | CA2654809C Polyketal compounds, synthesis, and applications |
| 03/29/2011 | CA2631880C Chromane substituted benzimidazoles and their use as acid pump inhibitors |
| 03/29/2011 | CA2489276C Tricyclic steroid hormone nuclear receptor modulators |
| 03/29/2011 | CA2469055C Aminotetralin derivatives as muscarinic receptor antagonists |
| 03/29/2011 | CA2452845C Dye-sulfenates for dual phototherapy |
| 03/29/2011 | CA2443672C Aryl and biaryl piperidines used as mch antagonists |
| 03/29/2011 | CA2390164C Substituted 4h-chromene and analogs as activators of caspases and inducers of apoptosis and the use thereof |
| 03/29/2011 | CA2299139C 4-phenyl-pyridine derivatives |
| 03/24/2011 | WO2011035332A1 Pyrrolidinone carboxamide derivatives as chemerin-r ( chemr23 ) modulators |
| 03/24/2011 | WO2011034202A1 Chromene compound |
| 03/24/2011 | WO2011034078A1 Glycine compound |
| 03/24/2011 | WO2011032269A1 Cyclometalated dye complexes and their use in dye-sensitized solar cells |
| 03/24/2011 | WO2010147375A3 Method for screening for substance which inhibits interaction between beta amyloid peptide and vegf and inhibitor searched by same |
| 03/24/2011 | WO2010124201A3 Compositions and methods for treatment of cardiovascular disease |
| 03/24/2011 | US20110071298 Processes and Intermediates |
| 03/24/2011 | US20110071206 Modulators of ATP-Binding Cassette Transporters |
| 03/24/2011 | US20110071196 Compounds Which Selectively Modulate The CB2 Receptor |
| 03/24/2011 | US20110071182 Inhibitors of AKT Activity |
| 03/24/2011 | US20110071169 Preparation of polymorphic form of lapatinib ditosylate |
| 03/24/2011 | US20110071152 5-membered heterocycle-based p38 kinase inhibitors |
| 03/24/2011 | US20110071149 Selective kinase inhibitors |
| 03/24/2011 | US20110071145 Raf Modulators And Methods Of Use |
| 03/24/2011 | US20110071144 Quinazoline derivatives and pharmaceutical compositions containing them |
| 03/24/2011 | US20110071142 Identification and use of small molecules to modulate transcription factor function and to treat transcription factor associated diseases |
| 03/24/2011 | US20110071134 2-(amino-substituted)-4-aryl pyrimidines and related compounds useful for treating inflammatory diseases |
| 03/24/2011 | US20110071130 2-aminobenzimidazoles for treating neurodegenerative diseases |
| 03/24/2011 | US20110071084 Benzazepine derivatives useful as vasopressin antagonists |
| 03/24/2011 | US20110070192 Method of preparation of novel nucleoside analogs and uses |
| 03/24/2011 | CA2772689A1 Glycine compound |
| 03/23/2011 | EP2298783A1 Anti-viral nucleoside analogs and methods for treating viral infections, especially hiv infections |
| 03/23/2011 | EP2298763A1 Method for producing 1-biphenylmethylimidazole compound |
| 03/23/2011 | EP2298762A2 Heterobicyclic compounds with antibacterial activity |
| 03/23/2011 | EP2298761A1 HIV inhibiting pyrimidines derivatives |
| 03/23/2011 | EP2298759A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases |
| 03/23/2011 | EP2298758A1 Anabaseine derivatives useful in the treatment of neurodegenerative diseases |
| 03/23/2011 | EP2298748A2 Triazole compounds that modulate HSP90 activity |
| 03/23/2011 | EP2298746A1 4-amino- quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases |
| 03/23/2011 | EP2298743A1 5-membered heterocycle-based P38 kinase inhibitors |
| 03/23/2011 | EP2298741A1 1H-benzo[g]indole compounds and organic luminescence device using the same |
| 03/23/2011 | EP2298740A1 1-H-benzo[g]indole compounds and organic lightemitting device including the same |
| 03/23/2011 | EP2298737A1 Indole compounds and organic light-emitting device including the same |
| 03/23/2011 | EP2298332A1 BAFF, inhibitors thereof and their use in the modulation of the B-cell response |
| 03/23/2011 | EP2298305A1 4-(N-Phenylamino)-quinazolines/quinolines as inhibitors of tyrosine kinases |
| 03/23/2011 | EP2297134A1 Substituted pyridin-4 -yl-methyl sulfonamides as fungicides |
| 03/23/2011 | EP2297133A1 1, 2 disubstituted heterocyclic compounds |
| 03/23/2011 | EP2297118A1 N- (1, 1, 1, 3, 3, 3-hexafluoro-2-hydroxypropan-2-yl) benzyl-n' -arylcarbonylpiperaz ine derivatives |
| 03/23/2011 | EP2297115A2 Quinazoline derivatives |
| 03/23/2011 | EP2297112A1 Pyrazole compounds as ccr1 antagonists |
| 03/23/2011 | EP2297110A1 Indane derivatives as ampa receptor modulators |
| 03/23/2011 | EP2297102A1 Heteroaromatic monoamides as orexinin receptor antagonists |
| 03/23/2011 | EP2297098A1 Pyrrolidine derivatives as nk2 receptor antagonists |
| 03/23/2011 | EP2297096A2 Aryl ketone as mri |
| 03/23/2011 | EP2297089A1 Benzocycloheptane and benzoxepine derivatives |